Mylan Speclt Drug Patent Portfolio
Mylan Speclt owns 1 orange book drug protected by 6 US patents Given below is the list of Mylan Speclt's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6667344 | Bronchodilating compositions and methods | 22 Jun, 2021 | Expired |
| US6814953 | Bronchodilating compositions and methods | 22 Jun, 2021 | Expired |
| US7348362 | Bronchodilating β-agonist compositions and methods | 22 Jun, 2021 | Expired |
| US7462645 | Bronchodilating beta-agonist compositions and methods | 22 Jun, 2021 | Expired |
| US8623922 | Bronchodilating Beta-agonist compositions and methods | 22 Jun, 2021 | Expired |
| US9730890 | Bronchodilating beta-agonist compositions and methods | 22 Jun, 2021 | Expired |
Latest Legal Activities on Mylan Speclt's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Mylan Speclt.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 20 Sep, 2021 | US9730890 |
|
Maintenance Fee Reminder Mailed
Critical
| 05 Apr, 2021 | US9730890 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 02 Jun, 2020 | US7462645 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 18 Sep, 2019 | US7348362 |
|
Recordation of Patent Grant Mailed
Critical
| 15 Aug, 2017 | US9730890 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 15 Aug, 2017 | US9730890 |
|
Issue Notification Mailed
Critical
| 26 Jul, 2017 | US9730890 |
| Dispatch to FDC | 19 Jul, 2017 | US9730890 |
| Filing Receipt - Corrected | 19 Jul, 2017 | US9730890 |
| Mail-Record Petition Decision of Granted to Accept Delayed Payment of Issue Fee | 11 Jul, 2017 | US9730890 |
| Record Petition Decision of Granted to Accept Delayed Payment of Issue Fee | 11 Jul, 2017 | US9730890 |
| O.P. Petition Decision | 11 Jul, 2017 | US9730890 |
| Mail O.P. Petition Decision | 11 Jul, 2017 | US9730890 |
| Petition Entered | 17 Feb, 2017 | US9730890 |
| Supplemental Papers - Oath or Declaration | 17 Feb, 2017 | US9730890 |
Mylan Speclt's Family Patents
Mylan Speclt Drug List
Given below is the complete list of Mylan Speclt's drugs and the patents protecting them.
1. Perforomist
Perforomist is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6667344 | Bronchodilating compositions and methods |
22 Jun, 2021
(3 years ago)
| Expired |
| US6814953 | Bronchodilating compositions and methods |
22 Jun, 2021
(3 years ago)
| Expired |
| US7348362 | Bronchodilating β-agonist compositions and methods |
22 Jun, 2021
(3 years ago)
| Expired |
| US7462645 | Bronchodilating beta-agonist compositions and methods |
22 Jun, 2021
(3 years ago)
| Expired |
| US8623922 | Bronchodilating Beta-agonist compositions and methods |
22 Jun, 2021
(3 years ago)
| Expired |
| US9730890 | Bronchodilating beta-agonist compositions and methods |
22 Jun, 2021
(3 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Perforomist's drug page